Ann: CMO Appointment and Clinical Trials Update, page-142

Prestonian,

I'm not sure what purpose regurgitating old news is meant to serve, other than making people feel better about one of the poorest investments on the ASX

The cap raise was a joke....the largest shareholder didn't want to get diluted yet again I'm guessing. Let's not forget Packer and Murdoch were the two biggest shareholders in One Tel

Day to day fluctuations of the share price?...There are no real fluctuations..just down

As for Hugh Alsop... From my point of view, he has added nothing at all to this company. Where were his contacts when it came to placing stock, not only at a decent price but also into strong hands?....I would say 95% of the placement went to retail investors ( and I include soph investors in this group because they are retail investors who sign a form) and that took months to sort out

So Dr Williams's apparent excitement with his appointment is meaningless

I have no issue with you being positive about the company but what you are using to justify this positiveness is really no justification at all IMO ...fact remains DXB is a monumental flop as an investment, it was when they botched its listing in 2014 and looks like it will continue to be in the forseeable future

I really don't give a damn about people slinging arrows at me...I will continue to call it as I see it, that is to say without the rose coloured glasses that appear to be standard issue on this thread

Contrary to the views of some of the windbags here, my buy in price is not the issue here. the way my investment is being managed is!